Quantcast

Direct endothelial junction restoration results in significant tumor vascular normalization and metastasis inhibition in mice.

Research paper by Vijayendra V Agrawal, Sony S Maharjan, Kyeojin K Kim, Nam-Jung NJ Kim, Jimin J Son, Keunho K Lee, Hyun-Jung HJ Choi, Seung-Sik SS Rho, Sunjoo S Ahn, Moo-Ho MH Won, Sang-Jun SJ Ha, Gou Young GY Koh, Young-Myeong YM Kim, Young-Ger YG Suh, Young-Guen YG Kwon

Indexed on: 09 May '14Published on: 09 May '14Published in: Oncotarget



Abstract

Tumor blood vessels are leaky and immature, which causes inadequate blood supply to tumor tissues resulting in hypoxic microenvironment and promotes metastasis. Here we have explored tumor vessel modulating activity of Sac-1004, a recently developed molecule in our lab, which directly potentiates VE-cadherin-mediated endothelial cell junction. Sac-1004 could enhance vascular junction integrity in tumor vessels and thereby inhibit vascular leakage and enhance vascular perfusion. Improved perfusion enabled Sac-1004 to have synergistic anti-tumor effect on cisplatin-mediated apoptosis of tumor cells. Interestingly, characteristics of normalized blood vessels namely reduced hypoxia, improved pericyte coverage and decreased basement membrane thickness were readily observed in tumors treated with Sac-1004. Remarkably, Sac-1004 was also able to inhibit lung and lymph node metastasis in MMTV and B16BL6 tumor models. This was in correlation with a reduction in epithelial-to-mesenchymal transition of tumor cells with considerable diminution in expression of related transcription factors. Moreover, cancer stem cell population dropped substantially in Sac-1004 treated tumor tissues. Taken together, our results showed that direct restoration of vascular junction could be a significant strategy to induce normalization of tumor blood vessels and reduce metastasis.